mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.04 |